

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.93263238 |
| 2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.79754605 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.49869976 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.49869976 |
| 5 | neutrophil activation involved in immune response (GO:0002283) | 5.25355884 |
| 6 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.90629524 |
| 7 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.75055384 |
| 8 | ribosomal small subunit assembly (GO:0000028) | 4.71004086 |
| 9 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.64958781 |
| 10 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.64958781 |
| 11 | modulation by symbiont of host immune response (GO:0052553) | 4.64958781 |
| 12 | positive regulation by symbiont of host defense response (GO:0052509) | 4.64958781 |
| 13 | modulation by symbiont of host defense response (GO:0052031) | 4.64958781 |
| 14 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.64958781 |
| 15 | macrophage activation involved in immune response (GO:0002281) | 4.46767484 |
| 16 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.46610454 |
| 17 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.34748716 |
| 18 | microglial cell activation (GO:0001774) | 4.28833632 |
| 19 | DNA deamination (GO:0045006) | 4.24248152 |
| 20 | cellular extravasation (GO:0045123) | 4.23984483 |
| 21 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.23932778 |
| 22 | regulation of gamma-delta T cell activation (GO:0046643) | 4.17666428 |
| 23 | detection of other organism (GO:0098543) | 4.15478739 |
| 24 | neutrophil activation (GO:0042119) | 4.14099200 |
| 25 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.10048038 |
| 26 | negative regulation of interleukin-12 production (GO:0032695) | 4.03928550 |
| 27 | positive regulation of B cell differentiation (GO:0045579) | 4.01574914 |
| 28 | detection of bacterium (GO:0016045) | 4.01503985 |
| 29 | negative regulation of T cell mediated immunity (GO:0002710) | 3.99843470 |
| 30 | activated T cell proliferation (GO:0050798) | 3.86073888 |
| 31 | myeloid cell activation involved in immune response (GO:0002275) | 3.83293548 |
| 32 | regulation of B cell differentiation (GO:0045577) | 3.82508337 |
| 33 | immunoglobulin mediated immune response (GO:0016064) | 3.77492103 |
| 34 | leukocyte aggregation (GO:0070486) | 3.76208192 |
| 35 | granulocyte activation (GO:0036230) | 3.73451902 |
| 36 | response to peptidoglycan (GO:0032494) | 3.69523300 |
| 37 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.68378905 |
| 38 | negative T cell selection (GO:0043383) | 3.67743735 |
| 39 | respiratory burst (GO:0045730) | 3.66885327 |
| 40 | negative thymic T cell selection (GO:0045060) | 3.65996321 |
| 41 | mast cell activation (GO:0045576) | 3.65457557 |
| 42 | interferon-gamma production (GO:0032609) | 3.64738883 |
| 43 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.63811922 |
| 44 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.63525878 |
| 45 | viral transcription (GO:0019083) | 3.61687560 |
| 46 | response to interleukin-15 (GO:0070672) | 3.61290256 |
| 47 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.55640242 |
| 48 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.53812614 |
| 49 | negative regulation of cell killing (GO:0031342) | 3.53812614 |
| 50 | positive thymic T cell selection (GO:0045059) | 3.52526989 |
| 51 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.49156452 |
| 52 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.47800946 |
| 53 | leukocyte degranulation (GO:0043299) | 3.47468921 |
| 54 | translational termination (GO:0006415) | 3.46904820 |
| 55 | definitive hemopoiesis (GO:0060216) | 3.46422971 |
| 56 | regulation of T cell tolerance induction (GO:0002664) | 3.46418156 |
| 57 | T cell homeostasis (GO:0043029) | 3.45880858 |
| 58 | positive regulation of mast cell activation (GO:0033005) | 3.44955363 |
| 59 | detection of external biotic stimulus (GO:0098581) | 3.43245765 |
| 60 | response to interferon-beta (GO:0035456) | 3.42758988 |
| 61 | cellular response to interleukin-15 (GO:0071350) | 3.42730163 |
| 62 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.40790215 |
| 63 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.40527448 |
| 64 | regulation of mast cell degranulation (GO:0043304) | 3.36260856 |
| 65 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.36177105 |
| 66 | response to host immune response (GO:0052572) | 3.36177105 |
| 67 | regulation of tolerance induction (GO:0002643) | 3.35461376 |
| 68 | T cell migration (GO:0072678) | 3.35366622 |
| 69 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.32458201 |
| 70 | B cell mediated immunity (GO:0019724) | 3.32438842 |
| 71 | macrophage activation (GO:0042116) | 3.32179756 |
| 72 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.28459736 |
| 73 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.28080723 |
| 74 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.23674514 |
| 75 | B cell receptor signaling pathway (GO:0050853) | 3.22834904 |
| 76 | megakaryocyte development (GO:0035855) | 3.22271885 |
| 77 | response to type I interferon (GO:0034340) | 3.19760353 |
| 78 | defense response to protozoan (GO:0042832) | 3.18980311 |
| 79 | type I interferon signaling pathway (GO:0060337) | 3.18494529 |
| 80 | cellular response to type I interferon (GO:0071357) | 3.18494529 |
| 81 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.15608614 |
| 82 | detection of biotic stimulus (GO:0009595) | 3.14426334 |
| 83 | response to protozoan (GO:0001562) | 3.13691881 |
| 84 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.13546179 |
| 85 | mature B cell differentiation involved in immune response (GO:0002313) | 3.13510785 |
| 86 | detection of molecule of bacterial origin (GO:0032490) | 3.12161509 |
| 87 | neutrophil mediated immunity (GO:0002446) | 3.11714807 |
| 88 | regulation of mast cell activation (GO:0033003) | 3.11342172 |
| 89 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.11047327 |
| 90 | positive regulation of tolerance induction (GO:0002645) | 3.07987744 |
| 91 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.07499872 |
| 92 | dendritic cell chemotaxis (GO:0002407) | 3.06785801 |
| 93 | cellular response to interferon-beta (GO:0035458) | 3.06146924 |
| 94 | translational elongation (GO:0006414) | 3.05942514 |
| 95 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.05910337 |
| 96 | response to host (GO:0075136) | 3.05910337 |
| 97 | response to host defenses (GO:0052200) | 3.05910337 |
| 98 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.05607502 |
| 99 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.05523820 |
| 100 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.05523820 |
| 101 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.04899750 |
| 102 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.02014326 |
| 103 | thymic T cell selection (GO:0045061) | 3.00692921 |
| 104 | ribosomal small subunit biogenesis (GO:0042274) | 3.00228938 |
| 105 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.97447334 |
| 106 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.96964515 |
| 107 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.96588468 |
| 108 | mature B cell differentiation (GO:0002335) | 2.96310555 |
| 109 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.95829855 |
| 110 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.95467337 |
| 111 | dendritic cell migration (GO:0036336) | 2.95344791 |
| 112 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.94978620 |
| 113 | myeloid dendritic cell activation (GO:0001773) | 2.93499359 |
| 114 | platelet dense granule organization (GO:0060155) | 2.93113373 |
| 115 | lymphocyte homeostasis (GO:0002260) | 2.91607972 |
| 116 | tolerance induction (GO:0002507) | 2.90935842 |
| 117 | mast cell degranulation (GO:0043303) | 2.90107267 |
| 118 | mast cell activation involved in immune response (GO:0002279) | 2.90107267 |
| 119 | positive regulation of granulocyte differentiation (GO:0030854) | 2.89894045 |
| 120 | cotranslational protein targeting to membrane (GO:0006613) | 2.88163595 |
| 121 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.88113634 |
| 122 | maturation of SSU-rRNA (GO:0030490) | 2.87113287 |
| 123 | negative regulation of phagocytosis (GO:0050765) | 2.86257876 |
| 124 | protein targeting to ER (GO:0045047) | 2.86239258 |
| 125 | T cell receptor signaling pathway (GO:0050852) | 2.85393438 |
| 126 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.82778029 |
| 127 | positive T cell selection (GO:0043368) | 2.81868814 |
| 128 | regulation of response to interferon-gamma (GO:0060330) | 2.79393514 |
| 129 | lymphoid progenitor cell differentiation (GO:0002320) | 2.79360848 |
| 130 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.76643801 |
| 131 | T cell selection (GO:0045058) | 2.75599344 |
| 132 | leukocyte homeostasis (GO:0001776) | 2.75522131 |
| 133 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.74852702 |
| 134 | lymph node development (GO:0048535) | 2.74656337 |
| 135 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.74536618 |
| 136 | protein localization to endoplasmic reticulum (GO:0070972) | 2.74242642 |
| 137 | regulation of regulatory T cell differentiation (GO:0045589) | 2.73824606 |
| 138 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.72308155 |
| 139 | viral life cycle (GO:0019058) | 2.72066007 |
| 140 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.71152069 |
| 141 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.69214735 |
| 142 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.65822602 |
| 143 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.64727487 |
| 144 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.64727487 |
| 145 | positive regulation of isotype switching (GO:0045830) | 2.64353955 |
| 146 | DNA strand elongation (GO:0022616) | 2.62144149 |
| 147 | lymphocyte costimulation (GO:0031294) | 2.61980457 |
| 148 | NIK/NF-kappaB signaling (GO:0038061) | 2.61886219 |
| 149 | telomere maintenance via recombination (GO:0000722) | 2.61373874 |
| 150 | T cell costimulation (GO:0031295) | 2.61267057 |
| 151 | regulation of B cell mediated immunity (GO:0002712) | 2.61150476 |
| 152 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.59824477 |
| 153 | regulation of erythrocyte differentiation (GO:0045646) | 2.59513350 |
| 154 | response to interferon-alpha (GO:0035455) | 2.58523983 |
| 155 | natural killer cell activation (GO:0030101) | 2.56931992 |
| 156 | germinal center formation (GO:0002467) | 2.56646417 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.71634217 |
| 2 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.81105679 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.41267496 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.35046123 |
| 5 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.32523755 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.31161332 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.27310129 |
| 8 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.98100605 |
| 9 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.89205726 |
| 10 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.84837950 |
| 11 | MYC_22102868_ChIP-Seq_BL_Human | 2.81902748 |
| 12 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.79006333 |
| 13 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.63499495 |
| 14 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.58740765 |
| 15 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.56056266 |
| 16 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.55508903 |
| 17 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.48458337 |
| 18 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.44492507 |
| 19 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.42488624 |
| 20 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.42304490 |
| 21 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.41967895 |
| 22 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.37289307 |
| 23 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.32297881 |
| 24 | MYB_26560356_Chip-Seq_TH2_Human | 2.32097094 |
| 25 | * MAF_26560356_Chip-Seq_TH1_Human | 2.11596832 |
| 26 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.07980872 |
| 27 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.07864127 |
| 28 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.05750427 |
| 29 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.05653067 |
| 30 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.02632744 |
| 31 | * MYB_26560356_Chip-Seq_TH1_Human | 2.00996174 |
| 32 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.98694980 |
| 33 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.98192107 |
| 34 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.97610119 |
| 35 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.95354007 |
| 36 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.92621303 |
| 37 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.92373372 |
| 38 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.91900267 |
| 39 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.90275947 |
| 40 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.88898122 |
| 41 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.88661152 |
| 42 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.86785576 |
| 43 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.84526939 |
| 44 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.81804293 |
| 45 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.80522595 |
| 46 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80182523 |
| 47 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.76461090 |
| 48 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.70647302 |
| 49 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.69486519 |
| 50 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.68065778 |
| 51 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.66295986 |
| 52 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.65966752 |
| 53 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.65655188 |
| 54 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.64266991 |
| 55 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.64043007 |
| 56 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.59400758 |
| 57 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.58175077 |
| 58 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.57594219 |
| 59 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.56753327 |
| 60 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.56289114 |
| 61 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.55401063 |
| 62 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.54057106 |
| 63 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.53806224 |
| 64 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.53206530 |
| 65 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.50714982 |
| 66 | GATA1_19941826_ChIP-Seq_K562_Human | 1.48956215 |
| 67 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.48573000 |
| 68 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.48405093 |
| 69 | MAF_26560356_Chip-Seq_TH2_Human | 1.48325895 |
| 70 | GATA1_22025678_ChIP-Seq_K562_Human | 1.44490478 |
| 71 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.44442729 |
| 72 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.40044518 |
| 73 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.39369671 |
| 74 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.38889169 |
| 75 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.38704218 |
| 76 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.38304160 |
| 77 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.34057243 |
| 78 | SPI1_23127762_ChIP-Seq_K562_Human | 1.33768071 |
| 79 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.31861131 |
| 80 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.29431652 |
| 81 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.28372313 |
| 82 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.28278240 |
| 83 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.27616354 |
| 84 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.26576817 |
| 85 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.25740072 |
| 86 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24417535 |
| 87 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24227213 |
| 88 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.23039884 |
| 89 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.21245451 |
| 90 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18780014 |
| 91 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.18163025 |
| 92 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.16018018 |
| 93 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.15340825 |
| 94 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.15029831 |
| 95 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.13963072 |
| 96 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.13850321 |
| 97 | GATA2_19941826_ChIP-Seq_K562_Human | 1.12178317 |
| 98 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.10953472 |
| 99 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.10539547 |
| 100 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10384256 |
| 101 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.09983582 |
| 102 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09073495 |
| 103 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.09017114 |
| 104 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07960178 |
| 105 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.06992449 |
| 106 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.05234454 |
| 107 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.04888019 |
| 108 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.04800105 |
| 109 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02195834 |
| 110 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.02194969 |
| 111 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02065634 |
| 112 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.01946145 |
| 113 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.98300874 |
| 114 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.96882282 |
| 115 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.96810248 |
| 116 | GATA3_26560356_Chip-Seq_TH2_Human | 0.96227049 |
| 117 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.94345509 |
| 118 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.93757255 |
| 119 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.93334104 |
| 120 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92664120 |
| 121 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.91061199 |
| 122 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.90746461 |
| 123 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88894920 |
| 124 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88781195 |
| 125 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.88515531 |
| 126 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.88073152 |
| 127 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.87990783 |
| 128 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.87920444 |
| 129 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.87194846 |
| 130 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.85749235 |
| 131 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.85637220 |
| 132 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.85073258 |
| 133 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.79617608 |
| 134 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.79597655 |
| 135 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.78312256 |
| 136 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.78250550 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.89758353 |
| 2 | MP0005671_abnormal_response_to | 3.89073468 |
| 3 | MP0002396_abnormal_hematopoietic_system | 3.64718597 |
| 4 | MP0003763_abnormal_thymus_physiology | 3.64020521 |
| 5 | MP0000685_abnormal_immune_system | 3.37407900 |
| 6 | MP0009785_altered_susceptibility_to | 2.99557315 |
| 7 | MP0001800_abnormal_humoral_immune | 2.89666692 |
| 8 | MP0002398_abnormal_bone_marrow | 2.68651580 |
| 9 | MP0005025_abnormal_response_to | 2.66269201 |
| 10 | MP0002420_abnormal_adaptive_immunity | 2.64841515 |
| 11 | MP0002723_abnormal_immune_serum | 2.62380592 |
| 12 | MP0001819_abnormal_immune_cell | 2.61683463 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.60119760 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.58684085 |
| 15 | MP0005464_abnormal_platelet_physiology | 2.57283350 |
| 16 | MP0005387_immune_system_phenotype | 2.44874250 |
| 17 | MP0001790_abnormal_immune_system | 2.44874250 |
| 18 | MP0002166_altered_tumor_susceptibility | 2.44258445 |
| 19 | MP0004808_abnormal_hematopoietic_stem | 2.42953515 |
| 20 | MP0003436_decreased_susceptibility_to | 2.36036363 |
| 21 | MP0000716_abnormal_immune_system | 2.31666656 |
| 22 | MP0000689_abnormal_spleen_morphology | 2.25665472 |
| 23 | MP0002419_abnormal_innate_immunity | 2.24488334 |
| 24 | MP0002722_abnormal_immune_system | 2.21808425 |
| 25 | MP0009333_abnormal_splenocyte_physiolog | 2.21555926 |
| 26 | MP0003724_increased_susceptibility_to | 2.21135943 |
| 27 | MP0005397_hematopoietic_system_phenotyp | 2.12495311 |
| 28 | MP0001545_abnormal_hematopoietic_system | 2.12495311 |
| 29 | MP0001873_stomach_inflammation | 2.12332133 |
| 30 | MP0008260_abnormal_autophagy | 2.10098788 |
| 31 | MP0005174_abnormal_tail_pigmentation | 2.09264944 |
| 32 | MP0000465_gastrointestinal_hemorrhage | 2.08518351 |
| 33 | MP0002148_abnormal_hypersensitivity_rea | 2.08475826 |
| 34 | MP0002405_respiratory_system_inflammati | 2.07657961 |
| 35 | MP0005075_abnormal_melanosome_morpholog | 2.04406250 |
| 36 | MP0002429_abnormal_blood_cell | 2.03593592 |
| 37 | MP0010155_abnormal_intestine_physiology | 2.01302051 |
| 38 | MP0002006_tumorigenesis | 1.98927295 |
| 39 | MP0006082_CNS_inflammation | 1.97469235 |
| 40 | MP0000703_abnormal_thymus_morphology | 1.96307114 |
| 41 | MP0001853_heart_inflammation | 1.92609678 |
| 42 | MP0000490_abnormal_crypts_of | 1.89135507 |
| 43 | MP0003866_abnormal_defecation | 1.85556232 |
| 44 | MP0003693_abnormal_embryo_hatching | 1.75312658 |
| 45 | MP0001845_abnormal_inflammatory_respons | 1.66359050 |
| 46 | MP0010094_abnormal_chromosome_stability | 1.48536981 |
| 47 | MP0008058_abnormal_DNA_repair | 1.42602379 |
| 48 | MP0004947_skin_inflammation | 1.40650862 |
| 49 | MP0002095_abnormal_skin_pigmentation | 1.38419163 |
| 50 | MP0002933_joint_inflammation | 1.36452706 |
| 51 | MP0004883_abnormal_blood_vessel | 1.35952971 |
| 52 | MP0008469_abnormal_protein_level | 1.34887318 |
| 53 | MP0008007_abnormal_cellular_replicative | 1.34634104 |
| 54 | MP0004510_myositis | 1.33387845 |
| 55 | MP0009278_abnormal_bone_marrow | 1.31956425 |
| 56 | MP0003077_abnormal_cell_cycle | 1.30730144 |
| 57 | MP0008057_abnormal_DNA_replication | 1.29109735 |
| 58 | MP0000015_abnormal_ear_pigmentation | 1.24777905 |
| 59 | MP0002019_abnormal_tumor_incidence | 1.23782533 |
| 60 | MP0003303_peritoneal_inflammation | 1.22461583 |
| 61 | MP0003191_abnormal_cellular_cholesterol | 1.22322879 |
| 62 | MP0008004_abnormal_stomach_pH | 1.22249992 |
| 63 | MP0000858_altered_metastatic_potential | 1.21518682 |
| 64 | MP0003172_abnormal_lysosome_physiology | 1.14079100 |
| 65 | MP0003300_gastrointestinal_ulcer | 1.12037816 |
| 66 | MP0005310_abnormal_salivary_gland | 1.07935073 |
| 67 | MP0002132_abnormal_respiratory_system | 1.06504828 |
| 68 | MP0005166_decreased_susceptibility_to | 1.06503045 |
| 69 | MP0001986_abnormal_taste_sensitivity | 1.05125086 |
| 70 | MP0001533_abnormal_skeleton_physiology | 1.04223893 |
| 71 | MP0003111_abnormal_nucleus_morphology | 1.03690757 |
| 72 | MP0002277_abnormal_respiratory_mucosa | 1.02699642 |
| 73 | MP0003690_abnormal_glial_cell | 1.01392701 |
| 74 | MP0004957_abnormal_blastocyst_morpholog | 1.01070490 |
| 75 | MP0005451_abnormal_body_composition | 0.98184467 |
| 76 | MP0005164_abnormal_response_to | 0.94547758 |
| 77 | MP0005058_abnormal_lysosome_morphology | 0.94305244 |
| 78 | MP0003075_altered_response_to | 0.93577388 |
| 79 | MP0004147_increased_porphyrin_level | 0.90488005 |
| 80 | MP0001851_eye_inflammation | 0.87958910 |
| 81 | MP0000313_abnormal_cell_death | 0.86767986 |
| 82 | MP0000343_altered_response_to | 0.85494483 |
| 83 | MP0003448_altered_tumor_morphology | 0.84778632 |
| 84 | MP0004130_abnormal_muscle_cell | 0.82364852 |
| 85 | MP0003943_abnormal_hepatobiliary_system | 0.80246118 |
| 86 | MP0009763_increased_sensitivity_to | 0.80224792 |
| 87 | MP0006054_spinal_hemorrhage | 0.73910864 |
| 88 | MP0005390_skeleton_phenotype | 0.72802806 |
| 89 | MP0003045_fibrosis | 0.71831479 |
| 90 | MP0009764_decreased_sensitivity_to | 0.71457683 |
| 91 | MP0000477_abnormal_intestine_morphology | 0.67655401 |
| 92 | MP0004381_abnormal_hair_follicle | 0.67461158 |
| 93 | MP0005083_abnormal_biliary_tract | 0.66323836 |
| 94 | MP0003656_abnormal_erythrocyte_physiolo | 0.64821006 |
| 95 | MP0009765_abnormal_xenobiotic_induced | 0.64547380 |
| 96 | MP0000604_amyloidosis | 0.63212450 |
| 97 | MP0000371_diluted_coat_color | 0.62754332 |
| 98 | MP0003806_abnormal_nucleotide_metabolis | 0.62013378 |
| 99 | MP0003828_pulmonary_edema | 0.61256882 |
| 100 | MP0001663_abnormal_digestive_system | 0.60569752 |
| 101 | MP0005023_abnormal_wound_healing | 0.58052152 |
| 102 | MP0003183_abnormal_peptide_metabolism | 0.56881821 |
| 103 | MP0003786_premature_aging | 0.56827335 |
| 104 | MP0008873_increased_physiological_sensi | 0.56432084 |
| 105 | MP0008874_decreased_physiological_sensi | 0.56401109 |
| 106 | MP0010352_gastrointestinal_tract_polyps | 0.56188836 |
| 107 | MP0002998_abnormal_bone_remodeling | 0.55281524 |
| 108 | MP0002138_abnormal_hepatobiliary_system | 0.54311319 |
| 109 | MP0006292_abnormal_olfactory_placode | 0.52384775 |
| 110 | MP0002075_abnormal_coat/hair_pigmentati | 0.50969412 |
| 111 | MP0005381_digestive/alimentary_phenotyp | 0.49944673 |
| 112 | MP0000598_abnormal_liver_morphology | 0.49539423 |
| 113 | MP0002693_abnormal_pancreas_physiology | 0.49151607 |
| 114 | MP0010307_abnormal_tumor_latency | 0.47169359 |
| 115 | MP0002009_preneoplasia | 0.46135301 |
| 116 | MP0000350_abnormal_cell_proliferation | 0.46018544 |
| 117 | MP0008877_abnormal_DNA_methylation | 0.45801374 |
| 118 | MP0003795_abnormal_bone_structure | 0.45324803 |
| 119 | MP0004185_abnormal_adipocyte_glucose | 0.44922057 |
| 120 | MP0000249_abnormal_blood_vessel | 0.43784354 |
| 121 | MP0009642_abnormal_blood_homeostasis | 0.43386090 |
| 122 | MP0003638_abnormal_response/metabolism_ | 0.42628740 |
| 123 | MP0005376_homeostasis/metabolism_phenot | 0.42197947 |
| 124 | MP0003787_abnormal_imprinting | 0.42132265 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.36768925 |
| 2 | IgM deficiency (HP:0002850) | 5.24049066 |
| 3 | Myositis (HP:0100614) | 4.58525093 |
| 4 | Chronic otitis media (HP:0000389) | 4.45843881 |
| 5 | Thrombocytosis (HP:0001894) | 4.45042743 |
| 6 | Recurrent abscess formation (HP:0002722) | 4.25164664 |
| 7 | Recurrent bronchitis (HP:0002837) | 4.16437987 |
| 8 | Petechiae (HP:0000967) | 3.77417948 |
| 9 | Recurrent fungal infections (HP:0002841) | 3.71506128 |
| 10 | Gastrointestinal infarctions (HP:0005244) | 3.70933549 |
| 11 | Abnormality of T cells (HP:0002843) | 3.70646768 |
| 12 | Prolonged bleeding time (HP:0003010) | 3.69370161 |
| 13 | Aplastic anemia (HP:0001915) | 3.68987946 |
| 14 | Increased IgM level (HP:0003496) | 3.65364855 |
| 15 | Abnormality of T cell physiology (HP:0011840) | 3.62399284 |
| 16 | Recurrent bacterial skin infections (HP:0005406) | 3.57217364 |
| 17 | Panhypogammaglobulinemia (HP:0003139) | 3.55127654 |
| 18 | Recurrent viral infections (HP:0004429) | 3.55122362 |
| 19 | Eczematoid dermatitis (HP:0000976) | 3.50346259 |
| 20 | IgG deficiency (HP:0004315) | 3.43269092 |
| 21 | T lymphocytopenia (HP:0005403) | 3.40809105 |
| 22 | Keratoconjunctivitis sicca (HP:0001097) | 3.38519875 |
| 23 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.38294953 |
| 24 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.36829939 |
| 25 | Recurrent cutaneous fungal infections (HP:0011370) | 3.36829939 |
| 26 | Nasal polyposis (HP:0100582) | 3.28429392 |
| 27 | Abnormality of T cell number (HP:0011839) | 3.25916147 |
| 28 | Lymphopenia (HP:0001888) | 3.23007613 |
| 29 | Abnormality of the nasal mucosa (HP:0000433) | 3.19633959 |
| 30 | Abnormal platelet volume (HP:0011876) | 3.18741187 |
| 31 | Keratoconjunctivitis (HP:0001096) | 3.17195000 |
| 32 | Epistaxis (HP:0000421) | 3.14587470 |
| 33 | Severe combined immunodeficiency (HP:0004430) | 3.14375072 |
| 34 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.11481254 |
| 35 | Meningitis (HP:0001287) | 3.11427060 |
| 36 | Abnormal number of erythroid precursors (HP:0012131) | 3.08777241 |
| 37 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.08222188 |
| 38 | Abnormality of B cell number (HP:0010975) | 3.07619492 |
| 39 | B lymphocytopenia (HP:0010976) | 3.07619492 |
| 40 | Recurrent skin infections (HP:0001581) | 3.03466130 |
| 41 | Pulmonary infiltrates (HP:0002113) | 3.01086759 |
| 42 | Urticaria (HP:0001025) | 2.99920108 |
| 43 | Gingivitis (HP:0000230) | 2.94818984 |
| 44 | Combined immunodeficiency (HP:0005387) | 2.85501583 |
| 45 | Gastrointestinal inflammation (HP:0004386) | 2.84453643 |
| 46 | Agammaglobulinemia (HP:0004432) | 2.83980756 |
| 47 | Inflammation of the large intestine (HP:0002037) | 2.83522205 |
| 48 | Reticulocytopenia (HP:0001896) | 2.81729779 |
| 49 | Thyroiditis (HP:0100646) | 2.81057527 |
| 50 | Orchitis (HP:0100796) | 2.80072636 |
| 51 | Episodic fever (HP:0001954) | 2.78133764 |
| 52 | Mediastinal lymphadenopathy (HP:0100721) | 2.77723562 |
| 53 | Hypochromic microcytic anemia (HP:0004840) | 2.77632367 |
| 54 | Spontaneous hematomas (HP:0007420) | 2.76521407 |
| 55 | Pustule (HP:0200039) | 2.76108991 |
| 56 | Menorrhagia (HP:0000132) | 2.71587752 |
| 57 | Hypochromic anemia (HP:0001931) | 2.71548709 |
| 58 | Optic neuritis (HP:0100653) | 2.71501869 |
| 59 | Retrobulbar optic neuritis (HP:0100654) | 2.71501869 |
| 60 | Vasculitis (HP:0002633) | 2.70412592 |
| 61 | Stomatitis (HP:0010280) | 2.69377169 |
| 62 | Chronic diarrhea (HP:0002028) | 2.67833108 |
| 63 | Lymphoma (HP:0002665) | 2.67451655 |
| 64 | Abnormality of macrophages (HP:0004311) | 2.65218180 |
| 65 | Leukocytosis (HP:0001974) | 2.61884900 |
| 66 | Abnormal platelet function (HP:0011869) | 2.61569519 |
| 67 | Impaired platelet aggregation (HP:0003540) | 2.61569519 |
| 68 | Pulmonary embolism (HP:0002204) | 2.61428385 |
| 69 | Obstructive lung disease (HP:0006536) | 2.61286900 |
| 70 | Chronic obstructive pulmonary disease (HP:0006510) | 2.61286900 |
| 71 | Abnormality of eosinophils (HP:0001879) | 2.58268219 |
| 72 | Increased mean platelet volume (HP:0011877) | 2.57926952 |
| 73 | Joint swelling (HP:0001386) | 2.53037303 |
| 74 | Cellulitis (HP:0100658) | 2.52338978 |
| 75 | Granulocytopenia (HP:0001913) | 2.51737616 |
| 76 | Encephalitis (HP:0002383) | 2.51522467 |
| 77 | Anorexia (HP:0002039) | 2.49743943 |
| 78 | Type 2 muscle fiber atrophy (HP:0003554) | 2.48571263 |
| 79 | Recurrent sinusitis (HP:0011108) | 2.46998710 |
| 80 | Muscle fiber atrophy (HP:0100295) | 2.44212193 |
| 81 | Poikiloderma (HP:0001029) | 2.44196488 |
| 82 | Gingival bleeding (HP:0000225) | 2.43799760 |
| 83 | Abnormality of the prostate (HP:0008775) | 2.42949004 |
| 84 | Amaurosis fugax (HP:0100576) | 2.41693295 |
| 85 | Hypoplasia of the thymus (HP:0000778) | 2.38123988 |
| 86 | Bronchitis (HP:0012387) | 2.36801292 |
| 87 | Reduced antithrombin III activity (HP:0001976) | 2.33928828 |
| 88 | Abnormality of the fingertips (HP:0001211) | 2.31991154 |
| 89 | Microcytic anemia (HP:0001935) | 2.31854168 |
| 90 | Autoimmune hemolytic anemia (HP:0001890) | 2.30870353 |
| 91 | Gastrointestinal stroma tumor (HP:0100723) | 2.29871393 |
| 92 | Gangrene (HP:0100758) | 2.29704806 |
| 93 | Myelodysplasia (HP:0002863) | 2.29613429 |
| 94 | Osteomyelitis (HP:0002754) | 2.28272049 |
| 95 | Type I transferrin isoform profile (HP:0003642) | 2.28119716 |
| 96 | Purpura (HP:0000979) | 2.28000715 |
| 97 | Hemoptysis (HP:0002105) | 2.27880979 |
| 98 | Pallor (HP:0000980) | 2.24755688 |
| 99 | Colitis (HP:0002583) | 2.23624178 |
| 100 | Increased IgE level (HP:0003212) | 2.22975551 |
| 101 | Hypergammaglobulinemia (HP:0010702) | 2.21857937 |
| 102 | IgA deficiency (HP:0002720) | 2.20496270 |
| 103 | Eosinophilia (HP:0001880) | 2.20405156 |
| 104 | Acute myeloid leukemia (HP:0004808) | 2.19528448 |
| 105 | Vertigo (HP:0002321) | 2.19229958 |
| 106 | Interstitial pulmonary disease (HP:0006530) | 2.17790410 |
| 107 | Arterial thrombosis (HP:0004420) | 2.17631524 |
| 108 | Sepsis (HP:0100806) | 2.16783770 |
| 109 | Autoimmune thrombocytopenia (HP:0001973) | 2.16574370 |
| 110 | Chest pain (HP:0100749) | 2.13646642 |
| 111 | Albinism (HP:0001022) | 2.12756056 |
| 112 | Abnormality of the pleura (HP:0002103) | 2.12122952 |
| 113 | Abnormality of iron homeostasis (HP:0011031) | 2.11453593 |
| 114 | Acute hepatic failure (HP:0006554) | 2.07839621 |
| 115 | Increased serum ferritin (HP:0003281) | 2.07778841 |
| 116 | Chronic sinusitis (HP:0011109) | 2.07074432 |
| 117 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.05610839 |
| 118 | Hyperlipoproteinemia (HP:0010980) | 2.05239818 |
| 119 | Hepatosplenomegaly (HP:0001433) | 2.04120924 |
| 120 | Basal cell carcinoma (HP:0002671) | 2.03896247 |
| 121 | Polyneuropathy (HP:0001271) | 2.03427644 |
| 122 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.02784320 |
| 123 | Glomerulopathy (HP:0100820) | 2.01501890 |
| 124 | Agnosia (HP:0010524) | 2.01422880 |
| 125 | Vacuolated lymphocytes (HP:0001922) | 2.00476700 |
| 126 | Pancytopenia (HP:0001876) | 2.00300371 |
| 127 | Entropion (HP:0000621) | 1.99292670 |
| 128 | Abnormality of DNA repair (HP:0003254) | 1.98796452 |
| 129 | Papilloma (HP:0012740) | 1.97673619 |
| 130 | Verrucae (HP:0200043) | 1.97673619 |
| 131 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.91406283 |
| 132 | Skin ulcer (HP:0200042) | 1.91012348 |
| 133 | Keratitis (HP:0000491) | 1.90565187 |
| 134 | Skin rash (HP:0000988) | 1.89836601 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.71630436 |
| 2 | TXK | 3.55832098 |
| 3 | KIT | 3.07410209 |
| 4 | ZAP70 | 2.58667968 |
| 5 | JAK3 | 2.45736992 |
| 6 | TEC | 2.40431447 |
| 7 | BTK | 2.36546472 |
| 8 | TYK2 | 2.15051180 |
| 9 | IKBKE | 2.14140099 |
| 10 | BLK | 2.06281617 |
| 11 | FLT3 | 2.06260499 |
| 12 | IRAK4 | 2.03814114 |
| 13 | NME2 | 2.03444636 |
| 14 | TGFBR2 | 2.03152933 |
| 15 | TBK1 | 2.03069158 |
| 16 | EEF2K | 1.95538876 |
| 17 | CSF1R | 1.92126661 |
| 18 | PRPF4B | 1.82321622 |
| 19 | ACVR1B | 1.80264386 |
| 20 | KDR | 1.79926875 |
| 21 | ITK | 1.69701015 |
| 22 | STK10 | 1.67771122 |
| 23 | SYK | 1.67551228 |
| 24 | STK16 | 1.62979732 |
| 25 | EPHB1 | 1.62212745 |
| 26 | TGFBR1 | 1.58305243 |
| 27 | FGR | 1.53511216 |
| 28 | MAP3K12 | 1.52205831 |
| 29 | LCK | 1.49574535 |
| 30 | PIK3CG | 1.42338975 |
| 31 | NLK | 1.38344905 |
| 32 | MAP2K3 | 1.37869839 |
| 33 | TNIK | 1.33504957 |
| 34 | IKBKB | 1.31003268 |
| 35 | WEE1 | 1.27906507 |
| 36 | FES | 1.25934126 |
| 37 | FGFR4 | 1.22267417 |
| 38 | MAP3K3 | 1.19530262 |
| 39 | GRK6 | 1.18252737 |
| 40 | TAOK1 | 1.16801912 |
| 41 | PIM2 | 1.14430594 |
| 42 | HCK | 1.14335933 |
| 43 | LYN | 1.11999175 |
| 44 | BMPR2 | 1.11748922 |
| 45 | MAP3K14 | 1.08980656 |
| 46 | JAK1 | 1.08624471 |
| 47 | RPS6KA4 | 1.05653066 |
| 48 | MUSK | 1.04630982 |
| 49 | CLK1 | 1.04342097 |
| 50 | TAOK3 | 1.03220141 |
| 51 | RPS6KB2 | 0.99944474 |
| 52 | PIM1 | 0.99397424 |
| 53 | MAP3K13 | 0.99371973 |
| 54 | CDK19 | 0.98505090 |
| 55 | LRRK2 | 0.97860858 |
| 56 | TNK2 | 0.96544854 |
| 57 | VRK1 | 0.91224783 |
| 58 | CSK | 0.88469237 |
| 59 | CAMKK2 | 0.88346429 |
| 60 | MAP3K1 | 0.85164709 |
| 61 | PRKCQ | 0.83871691 |
| 62 | SIK3 | 0.83611396 |
| 63 | MATK | 0.83086681 |
| 64 | CDC7 | 0.82685158 |
| 65 | TESK2 | 0.80036232 |
| 66 | PDK1 | 0.80006971 |
| 67 | BRSK2 | 0.78621716 |
| 68 | FGFR3 | 0.78353731 |
| 69 | IRAK1 | 0.77879744 |
| 70 | IRAK3 | 0.77586016 |
| 71 | PTK2B | 0.76943083 |
| 72 | NEK2 | 0.76132819 |
| 73 | BUB1 | 0.75491691 |
| 74 | MAP2K6 | 0.74946631 |
| 75 | AKT3 | 0.72619093 |
| 76 | YES1 | 0.72534092 |
| 77 | CDK4 | 0.70015773 |
| 78 | TAOK2 | 0.69509608 |
| 79 | SCYL2 | 0.69245169 |
| 80 | PKN2 | 0.68722529 |
| 81 | ATR | 0.67468173 |
| 82 | MAPKAPK3 | 0.67193111 |
| 83 | ADRBK2 | 0.66813643 |
| 84 | CDK8 | 0.65987814 |
| 85 | FYN | 0.65036515 |
| 86 | EIF2AK1 | 0.64263434 |
| 87 | CAMKK1 | 0.63209103 |
| 88 | SIK2 | 0.62629160 |
| 89 | EIF2AK3 | 0.62622589 |
| 90 | MARK3 | 0.62455255 |
| 91 | CCNB1 | 0.60517553 |
| 92 | ERN1 | 0.59920435 |
| 93 | MAPK11 | 0.59662426 |
| 94 | MAPK12 | 0.58080827 |
| 95 | PAK4 | 0.55324690 |
| 96 | EPHA3 | 0.54592266 |
| 97 | DYRK3 | 0.54434497 |
| 98 | PDPK1 | 0.53369243 |
| 99 | SGK2 | 0.52721602 |
| 100 | CDK7 | 0.52369367 |
| 101 | MAP3K5 | 0.51356156 |
| 102 | GRK7 | 0.51230033 |
| 103 | MAPKAPK5 | 0.49446563 |
| 104 | TSSK6 | 0.49072476 |
| 105 | RIPK4 | 0.48820484 |
| 106 | PASK | 0.48115520 |
| 107 | MARK2 | 0.47626488 |
| 108 | BMX | 0.47390092 |
| 109 | PRKD2 | 0.46949220 |
| 110 | CHUK | 0.46776682 |
| 111 | SGK3 | 0.46391464 |
| 112 | JAK2 | 0.46086168 |
| 113 | MAPK4 | 0.44961147 |
| 114 | MAP3K11 | 0.43686042 |
| 115 | IRAK2 | 0.43091504 |
| 116 | STK11 | 0.42417440 |
| 117 | RAF1 | 0.41237608 |
| 118 | TAF1 | 0.40708557 |
| 119 | TLK1 | 0.39102204 |
| 120 | MKNK1 | 0.39009707 |
| 121 | MAP3K10 | 0.38414172 |
| 122 | PRKG2 | 0.38332323 |
| 123 | HIPK2 | 0.38291410 |
| 124 | MAPKAPK2 | 0.38108884 |
| 125 | PTK6 | 0.38004657 |
| 126 | CAMK1 | 0.36752592 |
| 127 | MAP3K7 | 0.36249585 |
| 128 | DAPK1 | 0.36064461 |
| 129 | MAPK7 | 0.35360248 |
| 130 | RET | 0.35249732 |
| 131 | MAP3K6 | 0.34636650 |
| 132 | STK4 | 0.34592038 |
| 133 | KSR1 | 0.32793367 |
| 134 | MAP2K2 | 0.32473915 |
| 135 | ILK | 0.32349976 |
| 136 | RPS6KA6 | 0.31811611 |
| 137 | MAP3K8 | 0.31311830 |
| 138 | DYRK1B | 0.29622210 |
| 139 | KSR2 | 0.29044000 |
| 140 | PRKCD | 0.29011512 |
| 141 | MAP2K4 | 0.27508098 |
| 142 | ABL1 | 0.26940149 |
| 143 | GRK5 | 0.26883102 |
| 144 | RPS6KC1 | 0.26587729 |
| 145 | RPS6KL1 | 0.26587729 |
| 146 | RIPK1 | 0.26230645 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.01767616 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 3.32324287 |
| 3 | Ribosome_Homo sapiens_hsa03010 | 2.93609347 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 2.51015112 |
| 5 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.37748671 |
| 6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.31061131 |
| 7 | Measles_Homo sapiens_hsa05162 | 2.26671604 |
| 8 | Base excision repair_Homo sapiens_hsa03410 | 2.20620404 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.20193150 |
| 10 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.13624312 |
| 11 | Leishmaniasis_Homo sapiens_hsa05140 | 2.12753356 |
| 12 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.11813463 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.07982115 |
| 14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.07237343 |
| 15 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.00733928 |
| 16 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.00269176 |
| 17 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.88817638 |
| 18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.82592107 |
| 19 | Homologous recombination_Homo sapiens_hsa03440 | 1.80976989 |
| 20 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.77589354 |
| 21 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.66117691 |
| 22 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.64765938 |
| 23 | Spliceosome_Homo sapiens_hsa03040 | 1.59397675 |
| 24 | Other glycan degradation_Homo sapiens_hsa00511 | 1.57770746 |
| 25 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.52257018 |
| 26 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.45234737 |
| 27 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.44386678 |
| 28 | Allograft rejection_Homo sapiens_hsa05330 | 1.43426376 |
| 29 | Shigellosis_Homo sapiens_hsa05131 | 1.33474823 |
| 30 | RNA polymerase_Homo sapiens_hsa03020 | 1.32243554 |
| 31 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.27497054 |
| 32 | Proteasome_Homo sapiens_hsa03050 | 1.26550451 |
| 33 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.23427805 |
| 34 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.22505174 |
| 35 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.21453789 |
| 36 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.17772242 |
| 37 | Influenza A_Homo sapiens_hsa05164 | 1.16666925 |
| 38 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.14075137 |
| 39 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.13585455 |
| 40 | Legionellosis_Homo sapiens_hsa05134 | 1.12939292 |
| 41 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.12147256 |
| 42 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.11517351 |
| 43 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.11263402 |
| 44 | Hepatitis B_Homo sapiens_hsa05161 | 1.09525899 |
| 45 | Phagosome_Homo sapiens_hsa04145 | 1.08752832 |
| 46 | Platelet activation_Homo sapiens_hsa04611 | 1.08001152 |
| 47 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.07998736 |
| 48 | RNA degradation_Homo sapiens_hsa03018 | 1.07484306 |
| 49 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.07121412 |
| 50 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.03410602 |
| 51 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.02846395 |
| 52 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.01569075 |
| 53 | Pertussis_Homo sapiens_hsa05133 | 1.01503203 |
| 54 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.99964186 |
| 55 | Cell cycle_Homo sapiens_hsa04110 | 0.98627828 |
| 56 | Apoptosis_Homo sapiens_hsa04210 | 0.97990082 |
| 57 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.94495343 |
| 58 | Malaria_Homo sapiens_hsa05144 | 0.93984552 |
| 59 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.92931545 |
| 60 | Asthma_Homo sapiens_hsa05310 | 0.91764672 |
| 61 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.90919595 |
| 62 | Viral myocarditis_Homo sapiens_hsa05416 | 0.88454830 |
| 63 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.87450989 |
| 64 | Tuberculosis_Homo sapiens_hsa05152 | 0.87352697 |
| 65 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.86510598 |
| 66 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.85736519 |
| 67 | Basal transcription factors_Homo sapiens_hsa03022 | 0.84622441 |
| 68 | RNA transport_Homo sapiens_hsa03013 | 0.83128983 |
| 69 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.81954471 |
| 70 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.79759034 |
| 71 | HTLV-I infection_Homo sapiens_hsa05166 | 0.78769860 |
| 72 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.76586678 |
| 73 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.74594017 |
| 74 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.74532877 |
| 75 | Endocytosis_Homo sapiens_hsa04144 | 0.74250327 |
| 76 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.71984899 |
| 77 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.71076448 |
| 78 | Sulfur relay system_Homo sapiens_hsa04122 | 0.70845683 |
| 79 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.70567325 |
| 80 | Salmonella infection_Homo sapiens_hsa05132 | 0.68333963 |
| 81 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.66723733 |
| 82 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.64788627 |
| 83 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.64152214 |
| 84 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.63874835 |
| 85 | Purine metabolism_Homo sapiens_hsa00230 | 0.63711459 |
| 86 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.63689353 |
| 87 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.62584132 |
| 88 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.61985306 |
| 89 | Hepatitis C_Homo sapiens_hsa05160 | 0.60956423 |
| 90 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.60303640 |
| 91 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.57894885 |
| 92 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.55796406 |
| 93 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.55629699 |
| 94 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.53950978 |
| 95 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.53639568 |
| 96 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.52683417 |
| 97 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.51804004 |
| 98 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.51699870 |
| 99 | Colorectal cancer_Homo sapiens_hsa05210 | 0.51271131 |
| 100 | Protein export_Homo sapiens_hsa03060 | 0.49846701 |
| 101 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.49705364 |
| 102 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.48740875 |
| 103 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.48501456 |
| 104 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.48443944 |
| 105 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.47450491 |
| 106 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.46120601 |
| 107 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.45521619 |
| 108 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.45227749 |
| 109 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.43273959 |
| 110 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.42664564 |
| 111 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.42388124 |
| 112 | Thyroid cancer_Homo sapiens_hsa05216 | 0.42232769 |
| 113 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.40979612 |
| 114 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.39614612 |
| 115 | Lysosome_Homo sapiens_hsa04142 | 0.39306208 |
| 116 | Endometrial cancer_Homo sapiens_hsa05213 | 0.39135066 |
| 117 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.38580656 |
| 118 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.38558959 |
| 119 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.38387842 |
| 120 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.38276669 |
| 121 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.38023521 |
| 122 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.37772553 |
| 123 | Amoebiasis_Homo sapiens_hsa05146 | 0.37350055 |
| 124 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.36753215 |
| 125 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.35244807 |
| 126 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.35146514 |
| 127 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.34963672 |
| 128 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.34726360 |
| 129 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.34163844 |
| 130 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.32883060 |
| 131 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.31128729 |
| 132 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.30396693 |
| 133 | Long-term potentiation_Homo sapiens_hsa04720 | 0.29054263 |
| 134 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.27848745 |
| 135 | Insulin resistance_Homo sapiens_hsa04931 | 0.27602349 |
| 136 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.27268476 |

